Mark Kockx
- Immunology top 0.5%
- Atherosclerosis and Cardiovascular Diseases 27
- Immunotherapy and Immune Responses 13
- Phagocytosis and Immune Regulation 10
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 17
- Immunology and Allergy top 1%
- Cell Adhesion Molecules Research 14
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 29
-
- Cell death mechanisms and regulation 15
-
- Coronary Interventions and Diagnostics 13
- Co-authors
- Guido R.Y. De MeyerWim MartinetArnold G. HermanMichiel KnaapenHidde BultD. SchrijversLuc AndriesWillem Jacob
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (15 papers)Journal of Clinical Oncology (11 papers)Circulation (8 papers)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Mark Kockx
174 papers receiving 9.0k citations
Peers
Comparison fields: 5 of 147
- Immunology 2.5k
- Cancer Research 1.4k
- Immunology and Allergy 551
- Cardiology and Cardiovascular Medicine 1.2k
- Oncology 1.4k
Countries citing papers authored by Mark Kockx
This map shows the geographic impact of Mark Kockx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kockx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kockx more than expected).
Fields of papers citing papers by Mark Kockx
This network shows the impact of papers produced by Mark Kockx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kockx. The network helps show where Mark Kockx may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Kockx, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 5 | |
| 4 | 2021 | 9 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 31 | |
| 7 | 2017 | 28 | |
| 8 | 2017 | 12 | |
| 9 | 2016 | 24 | |
| 10 | 2007 | 159 | |
| 11 | 2007 | 15 | |
| 12 | 2004 | 26 | |
| 13 | 2002 | 36 | |
| 14 | Description of Agelas cerebrum, a new species and redescription of A. dilata | 2001 | 1 |
| 15 | Recovery of endothelial function and coronary plaque stabilisation after lipid lowering in LDL-hypercholesterolaemic pigs | 2001 | 2 |
| 16 | 2001 | 107 | |
| 17 | 2001 | 12 | |
| 18 | 2000 | 137 | |
| 19 | 2000 | 208 | |
| 20 | 1998 | 24 |
About Mark Kockx
Mark Kockx is a scholar working on Immunology, Immunology and Allergy and Cancer Research, having authored 176 papers that have together received 9.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (29 papers), Atherosclerosis and Cardiovascular Diseases (27 papers), Cancer Genomics and Diagnostics (17 papers), Cell death mechanisms and regulation (15 papers), Cell Adhesion Molecules Research (14 papers), Immunotherapy and Immune Responses (13 papers), Coronary Interventions and Diagnostics (13 papers) and Phagocytosis and Immune Regulation (10 papers). The work is most often cited by research in Immunology (2.5k citations), Cancer Research (1.4k citations) and Immunology and Allergy (551 citations). Mark Kockx has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Guido R.Y. De Meyer, Wim Martinet, Arnold G. Herman, Michiel Knaapen, Hidde Bult, D. Schrijvers, Luc Andries, Willem Jacob, Hilde Bortier and A.G. Herman. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Clinical Oncology, Circulation, Cancer Research and Journal of Cardiovascular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.